Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial

Perger, E. ; Lyons, O.D. ; Inami, T. ; Smith, S. ; Floras, J.S. ; Logan, A.G. ; Bradley, T.D. ; Ryan, C.M. ; Delgado, D.H. ; Mak, S. ; Tomlinson, G. ; Leung, R.S. ; Morrison, D. ; Fitzpatrick, M. ; Mayer, P. ; Kimoff, R.J. ; Mielniczuk, L. ; Beanlands, R. ; Series, F. ; Fleetham, J.A. ; Ayas, N. ; Demers, C. ; Powles, A.C.P. ; Rinne, C. ; Giannouli, E. ; Povitz, M. ; Dal Nogare, A. ; Dunlap, M. ; Shanmugasundaram, M. ; Lorenzi-Filho, G. ; Drager, L. ; Bittencourt, L.R. ; Amodeo, C. ; Bertolami, A. ; Pedrosa, R.P. ; Perez, M.M. ; Canadell, P.L. ; Jimenez, J.F.M. ; Barbe, F. ; Mangado, N.P.G. ; Del Campo, F. ; Cantolla, J.D. ; Trigo, J.M.M. (Universidad de Zaragoza) ; Martinez, M.G. ; Arzt, M. ; Randerath, W. ; La Rovere, M.T. ; Parati, G. ; Tantucci, C. ; Braghiroli, A. ; Raccagni, D. ; Redolfi, S. ; de Roquefeuil, F. ; Goutorbe, F. ; Escourrou, P. ; d''Ortho, M.P. ; Puel, V. ; Tamisier, R. ; Williams, A. ; Kasai, T. ; Takata, Y. ; Chin, K. ; Murase, K. ; Narui, K. ; Tomita, Y. [...] Mostrar todos los autores (65)

Resumen: Despite its effectiveness in suppressing sleep disordered breathing (SDB), positive airway pressure therapy (PAP) is not always well tolerated by patients and long-term adherence can be problematic. Recently, two multicentre, randomised clinical trials (RCTs) tested the effects of PAP for patients with cardiovascular disease and co-existing SDB on morbidity and mortality with negative outcomes [1, 2]. Relatively poor adherence to PAP therapy (mean 3.7 and 3.3 h·day-1, respectively) in these two trials might have contributed to their poor results. Indeed, higher PAP use per day is associated with better clinical outcomes than lower use [3].

Idioma: Inglés

DOI: 10.1183/13993003.01626-2018

Año: 2019

Publicado en: EUROPEAN RESPIRATORY JOURNAL 53, 2 (2019), 1801626
ISSN: 0903-1936

Factor impacto JCR: 12.339 (2019)

Categ. JCR: RESPIRATORY SYSTEM rank: 4 / 64 = 0.062 (2019) - Q1 - T1

Factor impacto SCIMAGO: 3.398 - Pulmonary and Respiratory Medicine (Q1) - Medicine (miscellaneous) (Q1)

Tipo y forma: (PostPrint)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)